Immediate Impact

5 by Nobel laureates 28 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
2017 Standout
2 intermediate papers

Works of Thomas Hoock being referenced

A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis
2014

Author Peers

Author Last Decade Papers Cites
Thomas Hoock 104 93 54 263 189 9 544
Hiroshi Shin 53 63 103 192 157 9 508
Toshifumi Azuma 56 23 41 331 316 13 646
Eleonora Presman 66 22 97 463 98 10 629
Padmaja Kunapuli 54 55 32 384 92 14 543
Dana K. Tucker 27 110 29 217 170 7 529
Arkadiusz Welman 126 87 61 312 91 17 563
J S Hu 68 20 33 508 72 9 592
J. Blok 135 69 69 283 83 13 541
Inès Desanlis 86 60 66 284 56 9 542
Pietro Antonio Bernabei 85 26 34 306 46 19 511

All Works

Loading papers...

Rankless by CCL
2026